$CDLX News

Cardlytics, Inc. (CDLX) Q1 2026 Earnings Call Transcript

Cardlytics Sees Q2 Sales $35.000M-$40.000M vs $37.519M Est

Cardlytics Q1 Adj. EPS $(0.11) Beats $(0.21) Estimate, Sales $34.319M Miss $37.200M Estimate

Cardlytics shares are trading lower after the company reported Q4 financial results and issued Q1 sales guidance below estimates.

Cardlytics shares are trading lower after the company reported Q4 financial results and issued Q1 sales guidance below estimates.

Cardlytics Inc (NASDAQ:CDLX) Shares Drop on Weak Q1 Guidance Despite Q4 Revenue Beat

Cardlytics, Inc. (CDLX) Q4 2025 Earnings Call Transcript

Cardlytics Q4 Earnings Assessment

Cardlytics Sees Q1 Sales $35.000M-$40.000M vs $48.695M Est

Cardlytics Q4 Adj. EPS $0.03 Beats $(0.07) Estimate, Sales $56.095M Beat $54.450M Estimate

Preview: Cardlytics's Earnings

Cardlytics (CDLX) Upgraded to Buy: Here's What You Should Know

Teads Expands Executive Leadership Team with Appointment of Dani Cushion as CMO

Cardlytics shares are trading higher after the company announced the appointment of David Evans as its new Chief Financial Officer.

Cardlytics Appoints Company Alumnus David Evans as Chief Financial Officer

Cardlytics Appoints Company Alumnus David Evans as Chief Financial Officer, Effective Jan. 12

All You Need to Know About Cardlytics (CDLX) Rating Upgrade to Buy

Cardlytics (CDLX) Q3 2025 Earnings Call Transcript

Cardlytics shares are trading lower after the company reported worse-than-expected Q3 sales results.

Cardlytics Inc (CDLX) Q3 2025 Earnings Call Highlights: Navigating Challenges and Expanding ...